跳转至内容
Merck
所有图片(2)

Key Documents

911917

Sigma-Aldrich

NanoFabTx microfluidic chip

for 100-200 nm particles

别名:

Microfluidic kit, NanoFabTx, Nanoformulation

登录查看公司和协议定价


About This Item

分類程式碼代碼:
41116105
分類程式碼代碼:
41121800
NACRES:
NA.23

描述

Microfludic hardware kit component for synthesizing nanoparticles

Kit components :

  • Microfluidic chip x 1

品質等級

應用

advanced drug delivery

正在寻找类似产品? 访问 产品对比指南

一般說明

NanoFabTx microfluidic chip, for 100-200 nm particles is a component of our NanoFabTx microfluidic - nano, device kit for synthesis of 100-200 nm nanoparticles and liposomes (911593). The kit additionally includes a protocol, supporting manifold, tubing, and additional accessories for microfluidic-based synthesis.

應用

NanoFabTx microfluidic chips precisely control and manipulate fluids on the microscale. Their well-controlled geometries enable facile syntheses of monodisperse polymeric nanoparticles. NanoFabTx microfluidic chip, for 100-200 nm particles can be used as a replacement for the component in our NanoFabTx microfluidic - nano, device kit for synthesis of 100-200 nm nanoparticles and liposomes (911593).

法律資訊

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门